Late-onset adverse events of anti-PD1 therapy in melanoma patients: An observational study from MELBASE, a nationwide prospective cohortClémentine Carlet, Charlée Nardin, M.‐T. Leccia et al.|Journal of the American Academy of Dermatology|2021Cited by 9